Overview

Efficacy Study of Gene Therapy for The Treatment of Acute LHON Onset Within Three Months

Status:
Active, not recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Efficacy Study of Gene Therapy for The Treatment of Acute Leber's Hereditary Optic Neuropathy (LHON) onset within three months
Phase:
N/A
Details
Lead Sponsor:
Bin Li